These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8637450)

  • 21. The determinants of glycemic responses to diet restriction and weight loss in obesity and NIDDM.
    Markovic TP; Jenkins AB; Campbell LV; Furler SM; Kraegen EW; Chisholm DJ
    Diabetes Care; 1998 May; 21(5):687-94. PubMed ID: 9589225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic insulin resistance and defects in substrate utilization in cystic fibrosis.
    Hardin DS; LeBlanc A; Para L; Seilheimer DK
    Diabetes; 1999 May; 48(5):1082-7. PubMed ID: 10331413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of prior high-intensity exercise on glucose metabolism in normal and insulin-resistant men.
    Devlin JT; Horton ES
    Diabetes; 1985 Oct; 34(10):973-9. PubMed ID: 3930321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thermic effect of glucose in obese subjects studied by direct and indirect calorimetry.
    Pittet P; Chappuis P; Acheson K; De Techtermann F; Jéquier E
    Br J Nutr; 1976 Mar; 35(2):281-92. PubMed ID: 1252403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Normalization of carbohydrate-induced thermogenesis by fructose in insulin-resistant states.
    Simonson DC; Tappy L; Jequier E; Felber JP; DeFronzo RA
    Am J Physiol; 1988 Feb; 254(2 Pt 1):E201-7. PubMed ID: 3279802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus.
    Groop LC; Saloranta C; Shank M; Bonadonna RC; Ferrannini E; DeFronzo RA
    J Clin Endocrinol Metab; 1991 Jan; 72(1):96-107. PubMed ID: 1986032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of obesity on insulin action in NIDDM.
    Campbell PJ; Carlson MG
    Diabetes; 1993 Mar; 42(3):405-10. PubMed ID: 8432411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin-stimulated muscle glucose clearance in patients with NIDDM. Effects of one-legged physical training.
    Dela F; Larsen JJ; Mikines KJ; Ploug T; Petersen LN; Galbo H
    Diabetes; 1995 Sep; 44(9):1010-20. PubMed ID: 7657022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic alterations in middle-aged and elderly obese patients with type 2 diabetes.
    Meneilly GS; Elliott T
    Diabetes Care; 1999 Jan; 22(1):112-8. PubMed ID: 10333911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of the antilipolytic nicotinic acid analogue acipimox on whole-body and skeletal muscle glucose metabolism in patients with non-insulin-dependent diabetes mellitus.
    Vaag A; Skött P; Damsbo P; Gall MA; Richter EA; Beck-Nielsen H
    J Clin Invest; 1991 Oct; 88(4):1282-90. PubMed ID: 1918378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of carbohydrate availability following exercise on whole-body insulin action.
    Holtz KA; Stephens BR; Sharoff CG; Chipkin SR; Braun B
    Appl Physiol Nutr Metab; 2008 Oct; 33(5):946-56. PubMed ID: 18923570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenesis of obesity and diabetes mellitus: insights provided by indirect calorimetry in humans.
    Perseghin G
    Acta Diabetol; 2001; 38(1):7-21. PubMed ID: 11487178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utilization of glycogen but not plasma glucose is reduced in individuals with NIDDM during mild-intensity exercise.
    Colberg SR; Hagberg JM; McCole SD; Zmuda JM; Thompson PD; Kelley DE
    J Appl Physiol (1985); 1996 Nov; 81(5):2027-33. PubMed ID: 8941525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolution of glucose induced thermogenesis in obese subjects with and without diabetes: a six-year follow-up study.
    Golay A; Jallut D; Schutz Y; Felber JP; Jéquier E
    Int J Obes; 1991 Sep; 15(9):601-7. PubMed ID: 1960011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of exercise training in the prevention and treatment of insulin resistance and non-insulin-dependent diabetes mellitus.
    Ivy JL
    Sports Med; 1997 Nov; 24(5):321-36. PubMed ID: 9368278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two days of a very low calorie diet reduces endogenous glucose production in obese type 2 diabetic patients despite the withdrawal of blood glucose-lowering therapies including insulin.
    Jazet IM; Pijl H; Frölich M; Romijn JA; Meinders AE
    Metabolism; 2005 Jun; 54(6):705-12. PubMed ID: 15931603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of hepatic insulin action in obese type 2 diabetic patients.
    Staehr P; Hother-Nielsen O; Levin K; Holst JJ; Beck-Nielsen H
    Diabetes; 2001 Jun; 50(6):1363-70. PubMed ID: 11375337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Visceral adipose tissue impairs insulin secretion and insulin sensitivity but not energy expenditure in obesity.
    Macor C; Ruggeri A; Mazzonetto P; Federspil G; Cobelli C; Vettor R
    Metabolism; 1997 Feb; 46(2):123-9. PubMed ID: 9030815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between insulin-mediated glucose disposal and lipid metabolism in man.
    Lillioja S; Bogardus C; Mott DM; Kennedy AL; Knowler WC; Howard BV
    J Clin Invest; 1985 Apr; 75(4):1106-15. PubMed ID: 3886702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic aspects of exercise and weight reduction.
    Horton ES
    Med Sci Sports Exerc; 1986 Feb; 18(1):10-8. PubMed ID: 3959851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.